Record First Quarter Revenue
Net sales of $1.0 billion, a record first quarter for the company, up 24% year-over-year.
Strong Volume Growth
Module production of 4.3 GW in Q1 (approximately 3.0 GW U.S., 1.3 GW international) with volumes sold growing 31% year-over-year.
Significant Margin Expansion
Gross margin of 47% expanded approximately 6 percentage points year-over-year; adjusted EBITDA of $520 million (above the Q1 preview range of $400M–$500M) and adjusted EBITDA margin of 50%.
Net Income and EPS Improvement
Net income of $347 million, up 65% year-over-year, and diluted EPS of $3.22.
Robust Balance Sheet and Cash Position
Ended the quarter with $2.4 billion in cash, cash equivalents, restricted cash, and marketable securities and a net cash position of $2.0 billion (at the high end of the targeted resilient cash range of ~$1.5B–$2.0B).
Operational Efficiency and Cost Savings
Sales freight cost fell to ~$0.017 per watt (roughly half of Q1 last year); warehouse costs reduced by $22 million sequentially, part of a plan to rationalize ~$100 million of warehouse costs by 2027.
Technology Launch — CURE
CURE launch complete in Perrysburg and Series 6 line ramping; CURE expected to deliver up to ~8% more lifetime specific energy yield than crystalline silicon TOPCon and supports potential realization of up to $600 million of additional revenue from technology adjusters in the backlog (majority anticipated in 2027–2028).
Backlog and Bookings
Contracted backlog of 47.9 GW at an aggregate transaction price of $14.4 billion (exclusive of technology adjusters) with gross bookings of ~1.9 GW since the last call and 1.7 GW recorded in Q1 (0.9 GW U.S. at ~$0.34/W and 0.8 GW India).
High U.S. Utilization and Domestic Manufacturing Progress
U.S. facilities operated at ~96% utilization in Q1; South Carolina finishing facility on track for production start in 2026 with equipment installation begun this quarter, expected to improve freight, tariff, and domestic content outcomes and benefit from Section 45X tax credits.
Operating Cash Flow Improvement
Operating cash outflows of $215 million in Q1, a meaningful improvement from outflows of $608 million in Q1 2025; capital expenditures of $119 million focused on South Carolina finishing facility.